A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis. (Record no. 25268923)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01856 a2200541 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517052957.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201608s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1949-2553 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.18632/oncotarget.5610 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Zhu, Gui-Qi |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20160822 |
245 00 - TITLE STATEMENT | |
Title | A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Oncotarget |
Date of publication, distribution, etc. | Sep 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 26757-69 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Alkaline Phosphatase |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bilirubin |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cholagogues and Choleretics |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cholangitis, Sclerosing |
General subdivision | therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease Progression |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Liver |
General subdivision | pathology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Liver Transplantation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Metronidazole |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mycophenolic Acid |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Odds Ratio |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proportional Hazards Models |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Randomized Controlled Trials as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Research Design |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Severity of Illness Index |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ursodeoxycholic Acid |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Young Adult |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shi, Ke-Qing |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Huang, Gui-Qian |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wang, Li-Ren |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lin, Yi-Qian |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Braddock, Martin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chen, Yong-Ping |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zhou, Meng-Tao |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zheng, Ming-Hua |
773 0# - HOST ITEM ENTRY | |
Title | Oncotarget |
Related parts | vol. 6 |
-- | no. 29 |
-- | p. 26757-69 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.18632/oncotarget.5610">https://doi.org/10.18632/oncotarget.5610</a> |
Public note | Available from publisher's website |
No items available.